The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street’s enthusiasm may be misplaced and some other investments worth exploring instead.
Disney (DIS)
Consensus Price Target: $129.67 (35.5% implied return)
Founded by brothers Walt and Roy, Disney (NYSE:DIS) is a multinational entertainment conglomerate, renowned for its theme parks, movies, television networks, and merchandise.
Why Do We Steer Clear of DIS?
- Annual sales growth of 10.8% over the last five years lagged behind its consumer discretionary peers as its large revenue base made it difficult to generate incremental demand
- Poor free cash flow margin of 9.4% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
- ROIC of 7.3% reflects management’s challenges in identifying attractive investment opportunities
At $95.69 per share, Disney trades at 12.9x forward P/E. To fully understand why you should be careful with DIS, check out our full research report (it’s free).
Service International (SCI)
Consensus Price Target: $96.33 (24.3% implied return)
Founded in 1962, Service International (NYSE: SCI) is a leading provider of death care products and services in North America.
Why Do We Pass on SCI?
- Sluggish trends in its funeral services performed suggest customers aren’t adopting its solutions as quickly as the company hoped
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Service International is trading at $77.48 per share, or 18.1x forward P/E. Read our free research report to see why you should think twice about including SCI in your portfolio.
Phibro Animal Health (PAHC)
Consensus Price Target: $45.60 (45.8% implied return)
With a portfolio of approximately 800 product lines serving farmers and veterinarians in 90 countries, Phibro Animal Health (NASDAQ:PAHC) develops, manufactures, and markets health products for livestock and companion animals, including antibacterials, vaccines, nutritional supplements, and mineral additives.
Why Does PAHC Give Us Pause?
- Modest revenue base of $1.5 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Estimated sales growth of 2.2% for the next 12 months implies demand will slow from its two-year trend
- Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 0.8% for the last five years
Phibro Animal Health’s stock price of $31.27 implies a valuation ratio of 10x forward P/E. If you’re considering PAHC for your portfolio, see our FREE research report to learn more.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.